Latest United Therapeutics Corp (UTHR) Headlines Look

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest United Therapeutics Corp (UTHR) Headlines

Look for Shares of United Therapeutics to Potentially Rebound after Yesterday's 4.97% Sell Off
Comtex SmarTrend(R) - Tue Mar 11, 5:53PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $93.00 to a high of $100.10. Yesterday, the shares fell 5.0%, which took the trading range below the 3-day low of $97.42 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

United Therapeutics Set to Possibly Rebound After Yesterday's Selloff of 4.97%
Comtex SmarTrend(R) - Tue Mar 11, 5:53PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $93.00 to a high of $100.10. Yesterday, the shares fell 5.0%, which took the trading range below the 3-day low of $97.42 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

United Therapeutics Earnings Hindsight: Up 0.5% in Last 13 Days (UTHR)
Comtex SmarTrend(R) - Mon Mar 10, 7:49AM CDT
When United Therapeutics (NASDAQ:UTHR) reported earnings 13 days ago on February 25th, 2014, analysts, on average, expected the company to report earnings of $2.62 on sales of $297.8 million. The company actually reported EPS of $2.88 on sales of $289.0 million, beating EPS estimates by $0.26 and missing revenue estimates by $8.8 million. Shares of United Therapeutics have climbed from $100.50 to $100.96, representing a gain of 0.5% since the company reported earnings 13 days ago.

Jim Cramer: Happy Birthday, You Bogus Bull Market
at The Street - Fri Mar 07, 10:22AM CST
You've rallied 177%, yet many don't seem to believe you exist.

Stock Movements, Upcoming Conferences, Financial Results, and Public Offering Closings - Analyst Notes on Community Health Systems, United Therapeutics, Thoratec, AMRI, and Cytokinetics
PR Newswire - Wed Mar 05, 6:15AM CST
Editor Note: For more information about this release, please scroll to bottom.

InterMune Stuns Markets, but Is It Overvalued?
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 28, 5:03PM CST
InterMune told investors during its fourth quarter conference call that results from its phase 3 Ascend trial studying Esbriet in idiopathic pulmonary fibrosis, or IPF, would likely be released early in the second quarter. Investors ended up...

United Therapeutics Slips on Q4 Earnings Report - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 8:10AM CST
The company's revenues lagged expectations.

Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Feb 26, 9:26AM CST
Last week was marked by label expansion and mixed results on pipeline candidates.

United Therapeutics Falls 3.86% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Feb 25, 6:08PM CST
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $99.16 to a high of $106.89. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $101.71 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of United Therapeutics After 3.86% Loss
Comtex SmarTrend(R) - Tue Feb 25, 6:07PM CST
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $99.16 to a high of $106.89. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $101.71 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

United Therapeutics Q4 Revenue Misses, Stock Slides
at Investor's Business Daily - Tue Feb 25, 11:17AM CST
Biotech United Therapeutics (UTHR) missed Q4 sales estimates and reported higher-than-expected expenses Tuesday, sending shares down 1% in midday trading on the stock market today. The company said sales totaled $289 million, up 19% from the...

United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results
PR Newswire - Tue Feb 25, 5:00AM CST
-- Total Annual Revenues of $1.1 billion

Pipeline Progress at Pluristem - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 4:50PM CST
Pluristem recently announced that it has submitted its application to the U.S. Food and Drug Administration (FDA) to grant orphan drug designation to its PLX-PAD cells for the treatment of severe preeclampsia.

Cempra (CEMP) Jumps: Stock Adds 6.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 8:39AM CST
Cempra, Inc. was a big mover last session, as its shares rose just over 6% on the day.

The Zacks Analyst Blog Highlights: Sanofi, Regeneron Pharmaceuticals, United Therapeutics, Medivation and Idenix Pharmaceuticals
PR Newswire - Fri Feb 21, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Sanofi (NYSE:SNY-Free Report), Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN-Free Report), United Therapeutics Corporation (Nasdaq:UTHR-Free Report), Medivation, Inc. (Nasdaq:MDVN-Free Report) and Idenix Pharmaceuticals Inc. (Nasdaq:IDIX-Free Report).

3 Biotech Stocks to Bet on this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 8:39AM CST
It is not too late to join the biotech bandwagon.

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014
PR Newswire - Tue Feb 18, 5:00AM CST
United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2013 financial results before market open on Tuesday, February 25, 2014.

Pluristem Receives Key 3D Cell Expansion Patent in Australia
GlobeNewswire - Tue Feb 18, 2:00AM CST
Pluristem Therapeutics, Inc. (NasdaqSTI) (TASELTR), a leading developer of placenta-based cell therapies, today announced it has been granted a new patent by the Australian Patent Office. Patent #2007228341 covers the method and composition of matter for three-dimensional (3D) expansion of placental or adipose (fat) stromal cells, Pluristem's key technology platform. Patent claims also include methods of treatment using placental cells for numerous diseases including graft vs. host disease (GvHD), heart disease, stroke, burns, loss of tissue, loss of blood, anemia, and autoimmune disorders. Patents with similar claims have also been granted to Pluristem in Russia and in South Africa. This marks Pluristem's third patent issued in Australia and its 28th patent issued worldwide.

The Zacks Analyst Blog Highlights: CNA Financial, Loews, FBL Financial Group, Pluristem Therapeutics and United Therapeutics
PR Newswire - Wed Feb 05, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the CNA Financial Corp. (NYSE:CNA-Free Report), Loews Corp. (NYSE:L-Free Report), FBL Financial Group Inc. (NYSE:FFG-Free Report), Pluristem Therapeutics, Inc. (NasdaqSTI-Free Report) and United Therapeutics (Nasdaq:UTHR-Free Report).

Study on Pluristem's Placental Cells - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 4:40PM CST
Pluristem Therapeutics, Inc. (PSTI) recently announced that the NIAID will initiate a mechanism-of-action study to evaluate Pluristem's PLacental eXpanded RAD (PLX-RAD) cells for the treatment of acute radiation syndrome (ARS).

United Therapeutics Corp. (UTHR) Stock Research Links

UTHR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

191 Schools Honored for Academic Growth Success

Updated Category News Views 65

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Mastering Prescription Labels: Critical Insights for Safety

Updated Category News Views 27

Revolutionizing How We Approach Prescription Labels Prescription labels aren't just scraps of paper or stickers slapped on bottles; they're lifelines. The insight from pharmacy expert Sheldon Birch could turn a regular label into a powerful tool for health management. According to Birch, the label is often disregarded yet speaks volumes about the medication you've got in...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 59

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 120

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 55

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 109

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 55

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Charlotte's Top-Tier Home Sales Surge: A $15M Milestone

Updated Category News Views 67

Charlotte's Luxury Market: A Rapid Ascent Folks, buckle up, because the luxury home market in Charlotte isn't just on the rise—it's practically sky-high. Back in 2016, the idea of splashing out over $5 million on a house was almost unheard of in this neck of the woods. Only one brave soul did it at the time. Fast forward to this past year, and things are looking starkly...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 142

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 159

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding DraftKings Options Activity and Market Trends

Updated Category News Views 194

DraftKings: Analyzing Recent Options Activity In the world of financial trading, few stories capture attention quite like a company's options activity, especially when it comes to a prominent name such as DraftKings (NASDAQ: DKNG). Recently, significant bullish moves by major investors have been noted, illustrating a dynamic shift within the trading environment. Insights...

Continue Reading
Integrating Bitcoin into Modern Investment Strategies

Updated Category News Views 259

Why Bitcoin Is Essential in Today's Investment Landscape For many investors, Bitcoin remains a puzzling investment vehicle. A recent survey revealed that a significant portion of the population lacks confidence in the safety and reliability of cryptocurrencies. However, when industry leaders like BlackRock make statements regarding Bitcoin, it’s wise to take heed....

Continue Reading
Strengthening Global Ties: ICAC's Role in Combating Corruption

Updated Category News Views 240

Strengthening Global Ties: ICAC's Role in Combating Corruption In a significant development, the ICAC Commissioner Mr. Woo Ying-ming represented the International Association of Anti-Corruption Authorities (IAACA) at the G20 Anti-Corruption Working Group meeting, marking the first occasion for the ICAC to participate in such a global dialogue. The meeting brought together...

Continue Reading
FlexTV's New Release: A Drama of Love and Intrigue

Updated Category News Views 447

FlexTV Unveils English Adaptation of a Short Drama Mega Matrix Inc. (NYSE American: MPU) is thrilled to announce the premiere of its much-anticipated short drama Drink Me, Keep Me, Cut Me, now available in English on their streaming platform, FlexTV. This series offers viewers a tantalizing glimpse into the intricate relationship dynamics intertwined with love and...

Continue Reading
Canada Eases Mortgage Switch Process for Borrowers

Updated Category News Views 87

Canada's Mortgage Game-Changer: Easing Lender Switching In a bold move that could shake up the housing market, Canada’s banking regulator has rolled out a directive set to streamline how homeowners switch lenders during mortgage renewals. Finally! This change aims to chop through the red tape that often kept borrowers shackled to less favorable terms. The Short-Term...

Continue Reading